Non-genetic group specific component (GC) observed in a patient with acute non-lymphocytic leukemia.
This is the case of a male non-lymphocytic leukemia patient who continuously exhibited non-genetic group specific component (GC). The patient was hospitalized 10 months for treatment. The patient's GC type was GC 2-1A2 upon his admission to the hospital, which was consistent with his parents' type. The additional GC protein isoform appeared during treatment and was detected by polyacrylamide gel isoelectric focusing (PAGIEF). This acquired GC component corresponded to GC 1F in PAGIEF and was thought to have originated from GC 1A2 protein. This phenomenon most probably occurred due to a metabolic abnormality or modification of the GC molecule caused by the disease itself, or by chemotherapy.
Shindo
S
S
Department of Forensic Medicine, Akita University School of Medicine, Japan.
Yoshioka
N
N
Niitsu
H
H
Miura
A B
AB
D000328:Adult; D016026:Bone Marrow Transplantation / Q000502:physiology; D004591:Electrophoresis, Polyacrylamide Gel; D005500:Follow-Up Studies; D006650:Histocompatibility Testing; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000235:genetics / Q000628:therapy; D008297:Male; D010641:Phenotype; D014809:Vitamin D-Binding Protein / Q000235:genetics / Q000378:metabolism*
D014809:Vitamin D-Binding Protein